This firm fixed-price purchase order was awarded to Mckesson Corporation, a healthcare services and information technology company, by the Department of Veterans Affairs' Veterans Integrated Service Network 9 for the delivery of the pharmaceutical drug LEUKERAN (chlorambucil) 2mg. The contract has a ceiling value of $13,884.00 and an ultimate completion date of August 3, 2024. No set-aside designation was used. Mckesson has previously provided a variety of pharmaceutical products and services to...
This is a firm fixed price purchase order awarded to Mckesson Corporation, a healthcare services and information technology company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The contract is for the delivery of LEUKERAN, a pharmaceutical product, with a ceiling value of $41,702.00 and a completion date of May 31, 2024. The contract does not have a set-aside designation. Mckesson Corporation is the prime contractor and there is no information provided about...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs to Mckesson Corporation, a healthcare services and information technology company, for the provision of Leukeran (chlorambucil) 2mg tablets. The $14,439.25 contract has a period of performance through March 28, 2025. The award does not utilize a set-aside designation. Mckesson, the prime contractor, has provided a range of pharmaceutical products and services to various federal agencies through multiple...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to Mckesson Corporation, a healthcare services and information technology company, for the delivery of LEUKERAN (CHLORAMBUCIL) 2MG TAB BOTTLE. The award has a ceiling value of $14,439.25 and a completion date of December 26, 2024. Mckesson has previously provided a range of pharmaceutical products and services to various federal agencies, including the Department of...
This firm fixed price purchase order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to Mckesson Corporation, a healthcare services and information technology company. The $28,878.50 contract is for the delivery of LEUKERAN (CHLORAMBUCIL) 2MG TAB BOTTLE (2 BOTTLES) to support VA medical centers. No set-aside was used for this award. The award indicates that Mckesson has provided a range of pharmaceutical products and services to federal agencies such...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency within the Department of Veterans Affairs, to Mckesson Corporation, a prominent healthcare services and IT company. The contract, valued at $28,878.50, is for the delivery of 3 bottles of the pharmaceutical drug Leukeran (chlorambucil) 2mg tablets. The award does not have a set-aside designation. Mckesson Corporation is the prime contractor, and the contract performance...
This is a federal contract award to McKessonCorporation, a prominent healthcare services and IT company, by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA). The contract, valued at $14,439.25, is for the emergency procurement of Leukeran (chlorambucil) 2mg tablets. This is a firm fixed-price purchase order with a completion date of July 22, 2025. The contract does not have a set-aside designation, indicating McKessonCompetesmicro for this...
The Department of Veterans Affairs awarded a firm fixed price purchase order to Mckesson Corporation, valued at $13,884.00, for the emergency procurement of LEUKERAN 2MG pharmaceuticals. This order does not have a set-aside designation and is expected to be completed by June 18, 2024. Mckesson Corporation is a healthcare services and IT company that has provided various pharmaceutical products and services to federal agencies, including the Department of Justice's Bureau of Prisons, the...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Mckesson Corporation, a prominent healthcare services and IT company, for the pharmaceutical product LEUKERAN 2MG NDC: 80725-0610-25. The award, valued at $14,439.25, has an ultimate completion date of August 4, 2025. The contract is not set aside for any specific business category. Mckesson Corporation has a strong presence in federal healthcare contracting,...
This is a $57,757 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 to Mckesson Corporation, a for-profit healthcare services and IT company, for the pharmaceutical product LEUKERAN. The award does not utilize any set-aside designations. According to the information provided, Mckesson has a history of serving as a prime contractor for federal healthcare agencies, delivering a range of pharmaceutical products and services...